Abstract
Acute manifestations of Organophosphate Compound (OPC) poison are due to effect cholinergic excess. Others are intermediate syndrome [IMS], organophosphate induced delayed neuropathy [OPIND] and chronic organophosphate induced neuropsychiatric disorder [COPIND]. All these manifestation have specific period of occurrence and duration. There are very sparse reports of toxic demylination due to OPC poisoning. We report a case of Guillain-Barre Syndrome (GBS) due to toxic demyelination following OPC poison.
MeSH terms
-
Adult
-
Atropine / therapeutic use
-
Chlorpyrifos / poisoning*
-
Cholinesterase Inhibitors / therapeutic use
-
Cholinesterase Reactivators / therapeutic use
-
Gastric Lavage
-
Guillain-Barre Syndrome / chemically induced*
-
Guillain-Barre Syndrome / drug therapy
-
Guillain-Barre Syndrome / therapy
-
Humans
-
Insecticides / poisoning*
-
Male
-
Methylprednisolone / therapeutic use
-
Neuroprotective Agents / therapeutic use
-
Parasympatholytics / therapeutic use
-
Plasmapheresis
-
Pralidoxime Compounds / therapeutic use
Substances
-
Cholinesterase Inhibitors
-
Cholinesterase Reactivators
-
Insecticides
-
Neuroprotective Agents
-
Parasympatholytics
-
Pralidoxime Compounds
-
Atropine
-
Chlorpyrifos
-
pralidoxime
-
Methylprednisolone